Session Abstract – PMWC 2018 Silicon Valley
Session Synopsis: We see an emerging era of potential explosive growth of AI applications in healthcare, but the implementation and access to AI is challenged by isolated data stores and the high degree of complexity of the available tools. Furthermore, deep learning requires lots of data to train and refine models which, in turn, complicates and burdens compute systems as well as data movement. This panel will discuss AI and machine learning systems requirements, and potential paths to overcoming the challenges of AI implementation.
Session Chair Profile
M.D., Ph.D., Director, Institute for Computational Health Sciences, UCSF
Atul Butte, MD, PhD is the new Director of the new Institute of Computational Health Sciences (ICHS) at the University of California, San Francisco, and a Professor of Pediatrics. Dr. Butte trained in Computer Science at Brown University, worked as a software engineer at Apple and Microsoft, received his MD at Brown University, trained in Pediatrics and Pediatric Endocrinology at Children’s Hospital Boston, then received his PhD from Harvard Medical School and MIT. Dr. Butte has authored nearly 200 publications, with research repeatedly featured in Wired Magazine, the New York Times, and the Wall Street Journal. In 2013, Dr. Butte was recognized by the White House as an Open Science Champion of Change for promoting science through publicly available data. Dr. Butte is also a founder of three investor-backed data-driven companies: Personalis, providing clinical interpretation of whole genome sequences, Carmenta (acquired by Progenity), discovering diagnostics for pregnancy complications, and NuMedii, finding new uses for drugs through open molecular data. Dr. Butte is also the principal investigator of ImmPort, the clinical and molecular data repository for the National Institute of Allergy and Infectious Diseases.
Ph.D., Head of Healthcare & Life Sciences Strategy – Hewlett-Packard, HP Inc.
Dr. Ali Tinazli has a deep background in the science and business of biomedicine and healthcare. Ali has done extensive work in the field of molecular biology of aging and nanobiotechnology and has authored about 20 publications. He received his PhD in BioChemistry from J.W. Goethe University in Germany, and also studied business at UC, Berkeley’s Haas School of Business and MIT’s Sloan School of Management. After receiving his Ph.D., Ali was in Corporate Development at Applied Biosystems (now: Thermo Fisher) where he conducted technology scouting and in-licensing. From 2008-2015, Dr. Tinazli, built the biomedical consumables business at Sony DADC (part of SONY Corporation). As a member of the management team at Sony DADC BioSciences, he has headed as VP & Head of Business Development the Americas business based out of Cambridge, MA. In addition to his bioscience and industry domain experience, Ali brings strong entrepreneurial experience and hands-on knowledge of the biosciences start-up community.
J.D., Founder and CEO, Tempus
Eric Lefkofsky is a serial entrepreneur who has co-founded Groupon (NASDAQ: GRPN), Uptake Technologies, Mediaocean, Echo Global Logistics (NASDAQ: ECHO) and InnerWorkings (NASDAQ: INWK). He is also a founding partner of the venture fund Lightbank. In late 2015, Lefkofsky formed Tempus, with a goal of building the largest database of clinical and molecular data in the world, and an operating system to make that data accessible and useful to physicians and the patients they treat.
Global Director Life Sciences, Intel Corporation
Kristina Kermanshahche is Global Director Life Sciences at Intel Corporation, where she defines Intel’s Life Sciences business strategy and leads industry enabling, pathfinding investment and solution development worldwide. She is a valued thought leader, working with national governments and scientific experts alike to overcome systemic challenges, scale in silico bioinformatics pipelines to keep pace with the output of high throughput instruments, and foster the use of optimized AI and high performance computing, resulting in strategic, disruptive product innovation worldwide. Her 30-year career in software and service development spans nearly every industry, with an emphasis on complex distributed systems, parallelism, high availability, networking, and data science. Focused exclusively on health life sciences since 2005, she holds a patent in healthcare semantic interoperability. She received her B.A. degree from the Robert D. Clarke Honors College, University of Oregon, in Political Science and International Studies, magna cum laude. Member Phi Beta Kappa Society.